Form 8-K - Current report:
SEC Accession No. 0001193125-24-011267
Filing Date
2024-01-19
Accepted
2024-01-19 16:19:52
Documents
15
Period of Report
2024-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d664610d8k.htm   iXBRL 8-K 28988
2 EX-1.1 d664610dex11.htm EX-1.1 192810
3 EX-5.1 d664610dex51.htm EX-5.1 42299
7 GRAPHIC g664610gsa.jpg GRAPHIC 3301
  Complete submission text file 0001193125-24-011267.txt   460496

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prok-20240119.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE prok-20240119_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prok-20240119_pre.xml EX-101.PRE 11711
9 EXTRACTED XBRL INSTANCE DOCUMENT d664610d8k_htm.xml XML 3486
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 24545837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)